Status:
COMPLETED
Pain Control in Children and Adolescent After Thoracic Surgery: The Effect of Gabapentin
Lead Sponsor:
National Institute for Tuberculosis and Lung Diseases, Poland
Conditions:
Pain, Postoperative
Surgery, Thoracic
Eligibility:
All Genders
5-18 years
Phase:
PHASE4
Brief Summary
The study is performed in patients aged 5-18 years after thoracic surgery. The primary aim of this trial is to determine whether the use of gabapentin as a component of multimodal analgesic regiments ...
Detailed Description
The subjects are randomized to the Gabapentin or Placebo group. All patients receive preoperative gabapentin (15 mg/kg, treatment) or placebo, respectively and after surgery either gabapentin (7,5 mg/...
Eligibility Criteria
Inclusion
- 5 - 18 years of age;
- surgery: lateral thoracotomy or Ravitch procedure;
- ASA 1-3;
- postoperative analgesia: thoracic epidural analgesia or intravenous infusion of morphine.
Exclusion
- allergy or sensitivity to gabapentin;
- history of chronic pain or daily analgesic use;
- diagnosed with psychiatric disorders;
- treated oncologically;
- with impaired verbal communication;
- the lack of postoperative chest drainage.
Key Trial Info
Start Date :
May 9 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 3 2020
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT03393702
Start Date
May 9 2017
End Date
December 3 2020
Last Update
September 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Tuberculosis and Lung Diseases, Pediatric Division
Rabka-Zdrój, Małopolska, Poland, 34-700